A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea

NCT01381900 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

678

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo
DRUG: Canagliflozin 100mg
DRUG: Canagliflozin 300mg
DRUG: Metformin
DRUG: Sulphonylurea

Sponsor

Janssen Research & Development, LLC